BCR and chronic myelogenous leukemia, BCR-ABL1 positive: However, the attempt to use vaccines against chronic myelogenous leukemia (CML) by targeting the BCR-ABL fusion oncoprotein failed to prove a clear clinical benefit 77, 78.